CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury (Feb 2020)
October 24, 2022
We use cookies to ensure that we give you the best experience on our website. Please see our Privacy Policy for more information.
You can revoke your consent any time using the Revoke consent button.
